Metraipolis › archive › dc_d2a624a8dcaa
When Should Clinical Mycology Laboratories Perform Antifungal Susceptibility Testing? Revisiting Practice Through the Lens of Intrinsic Resistance — Europe PMC PMID:41422195
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41422195
- DOI
- 10.1007/s11046-[numero omesso]-6
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-07T12:03:22.142Z
- SHA-256 of the archived text
82417abff60736b0801a4887d846f91e9641519106a7b0e8c438cbb98a7a3edc- Stable URL of this page
https://metraipolis.com/documento/dc_d2a624a8dcaa
How to cite
When Should Clinical Mycology Laboratories Perform Antifungal Susceptibility Testing? Revisiting Practice Through the Lens of Intrinsic Resistance — Europe PMC PMID:41422195 — Europe PMC (en), https://europepmc.org/article/MED/41422195 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_d2a624a8dcaa (Metraipolis archive dc_d2a624a8dcaa, sha256 82417abff60736b0801a4887d846f91e9641519106a7b0e8c438cbb98a7a3edc)
BibTeX
@misc{dcd2a624a8dcaa,
title = {When Should Clinical Mycology Laboratories Perform Antifungal Susceptibility Testing? Revisiting Practice Through the Lens of Intrinsic Resistance — Europe PMC PMID:41422195},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41422195},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_d2a624a8dcaa; sha256 82417abff60736b0801a4887d846f91e9641519106a7b0e8c438cbb98a7a3edc},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41422195. Agents can read the archived copy with the MCP tool read_document.